Citigroup
NARI

Citigroup’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Citigroup’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-77,300
Closed -$5.06M – 5895
2023
Q3 		$5.06M Buy
+77,300
New +$4.86M ﹤0.01% 1425
2022
Q3 		– Sell
-20,000
Closed -$1.36M – 6429
2022
Q2 		$1.36M Buy
+20,000
New +$1.44M ﹤0.01% 2391

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Citigroup's NARI Position: Q1 2025 in Review

Citigroup sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 81,578 shares — an estimated $4.16M sold.

Citigroup first reported a position in NARI in Q3 2020 and held it in 18 quarters. The position peaked at $4.16M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Citigroup reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 81,578 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $4.16M.
  • Citigroup first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
  • Citigroup's Inari Medical, Inc. Common Stock position peaked at $4.16M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.